These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31249227)

  • 1. Effect of high-dose Omega 3 on lipid profile and inflammatory markers in chronic hemodialysis children.
    Omar ZA; Montser BA; Farahat MAR
    Saudi J Kidney Dis Transpl; 2019; 30(3):634-639. PubMed ID: 31249227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.
    Daud ZA; Tubie B; Adams J; Quainton T; Osia R; Tubie S; Kaur D; Khosla P; Sheyman M
    Vasc Health Risk Manag; 2012; 8():187-95. PubMed ID: 22536073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Double-Blinded, Placebo-Controlled Trial Investigating the Effect of Fish Oil Supplementation on Gene Expression Related to Insulin Action, Blood Lipids, and Inflammation in Gestational Diabetes Mellitus-Fish Oil Supplementation and Gestational Diabetes.
    Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Taghizadeh M; Asemi Z
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.
    Poreba M; Mostowik M; Siniarski A; Golebiowska-Wiatrak R; Malinowski KP; Haberka M; Konduracka E; Nessler J; Undas A; Gajos G
    Cardiovasc Diabetol; 2017 Apr; 16(1):50. PubMed ID: 28410617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients.
    Hung AM; Booker C; Ellis CD; Siew ED; Graves AJ; Shintani A; Abumrad NN; Himmelfarb J; Ikizler TA
    Nephrol Dial Transplant; 2015 Feb; 30(2):266-74. PubMed ID: 25204316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
    Tayyebi-Khosroshahi H; Houshyar J; Dehgan-Hesari R; Alikhah H; Vatankhah AM; Safaeian AR; Zonouz NR
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):500-6. PubMed ID: 22569435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients.
    Poulia KA; Panagiotakos DB; Tourlede E; Rezou A; Stamatiadis D; Boletis J; Zampelas A
    J Ren Nutr; 2011 Nov; 21(6):479-84. PubMed ID: 21439849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Effects of Omega-3 Fatty Acids on Insulin Resistance and Lipid Profile in Maintenance Hemodialysis Patients: a Randomized Placebo-Controlled Trial.
    Gharekhani A; Dashti-Khavidaki S; Lessan-Pezeshki M; Khatami MR
    Iran J Kidney Dis; 2016 Sep; 10(5):310-318. PubMed ID: 27721230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients.
    Asemi Z; Soleimani A; Shakeri H; Mazroii N; Esmaillzadeh A
    Int Urol Nephrol; 2016 Nov; 48(11):1887-1895. PubMed ID: 27554670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Omega-3 Fatty Acid Supplementation on Serum Biomarkers, Inflammatory Agents, and Quality of Life of Patients on Hemodialysis.
    Moeinzadeh F; Shahidi S; Mortazavi M; Dolatkhah S; Kajbaf M; Haghjooy Javanmard S; Moghtaderi A
    Iran J Kidney Dis; 2016 Nov; 10(6):381-387. PubMed ID: 27903997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients.
    Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Abdollahi A; Hashemi-Nazari SS; Mansournia MA
    J Ren Nutr; 2014 May; 24(3):177-85. PubMed ID: 24613294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Omega-3 Fatty Acids on Serum Lipid Profile and Oxidative Stress in Pediatric Patients on Regular Hemodialysis: A Randomized Placebo-Controlled Study.
    Ateya AM; Sabri NA; El Hakim I; Shaheen SM
    J Ren Nutr; 2017 May; 27(3):169-174. PubMed ID: 28110812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
    de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of omega-3 and vitamin E coadministration on gene expression of SIRT1 and PGC1α and serum antioxidant enzymes in patients with coronary artery disease.
    Saboori S; Koohdani F; Nematipour E; Yousefi Rad E; Saboor-Yaraghi AA; Javanbakht MH; Eshraghian MR; Ramezani A; Djalali M
    Nutr Metab Cardiovasc Dis; 2016 Jun; 26(6):489-94. PubMed ID: 27033026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between serum homocysteine and highly sensitive C- reactive protein levels in children on regular hemodialysis.
    Abdel-Salam M; Ibrahim S; Pessar SA; Al-Morsy E
    Saudi J Kidney Dis Transpl; 2017; 28(3):483-490. PubMed ID: 28540883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 supplementation effects on cardiovascular risk and inflammatory profile in chronic kidney disease patients in hemodialysis treatment: An intervention study.
    de Lima K; Mazur CE; Vicente Cavagnari MA; Castilho AJ; Schiessel DL
    Clin Nutr ESPEN; 2023 Dec; 58():144-151. PubMed ID: 38056999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
    Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
    J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis.
    Valle Flores JA; Fariño Cortéz JE; Mayner Tresol GA; Perozo Romero J; Blasco Carlos M; Nestares T
    Appl Physiol Nutr Metab; 2020 Aug; 45(8):805-811. PubMed ID: 31935118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
    Kooshki A; Taleban FA; Tabibi H; Hedayati M
    Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 polyunsaturated fatty acids and adiponectin in patients with end-stage renal disease.
    Harving F; Svensson M; Flyvbjerg A; Schmidt EB; Jørgensen KA; Eriksen HH; Christensen JH
    Clin Nephrol; 2015 May; 83(5):279-85. PubMed ID: 25816805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.